In This Article:
As the United Kingdom grapples with economic headwinds, including weak trade data from China and a faltering FTSE 100, investors are increasingly turning their attention to small-cap stocks for potential opportunities. In this challenging environment, identifying undervalued small-cap companies with insider action can provide a promising avenue for those looking to navigate the current market landscape effectively.
Top 10 Undervalued Small Caps With Insider Buying In The United Kingdom
| Name | PE | PS | Discount to Fair Value | Value Rating |
|---|---|---|---|---|
| Bytes Technology Group | 23.6x | 5.3x | 16.25% | ★★★★★☆ |
| C&C Group | NA | 0.4x | 47.87% | ★★★★★☆ |
| Essentra | 801.7x | 1.6x | 40.53% | ★★★★★☆ |
| GB Group | NA | 2.8x | 37.63% | ★★★★★☆ |
| Genus | 162.3x | 1.9x | 1.62% | ★★★★★☆ |
| CVS Group | 22.8x | 1.3x | 40.01% | ★★★★☆☆ |
| Norcros | 7.9x | 0.5x | -1.39% | ★★★☆☆☆ |
| NWF Group | 8.8x | 0.1x | 35.29% | ★★★☆☆☆ |
| Alpha Group International | 10.0x | 4.6x | -23.63% | ★★★☆☆☆ |
| Watkin Jones | NA | 0.2x | -1422.68% | ★★★☆☆☆ |
Here's a peek at a few of the choices from the screener.
Genus
Simply Wall St Value Rating: ★★★★★☆
Overview: Genus is a biotechnology company specializing in animal genetics, with a market cap of approximately £2.50 billion.
Operations: Genus generates revenue primarily from its Genus ABS and Genus PIC segments, with the latter contributing £352.50 million. The company's gross profit margin has shown significant fluctuations, reaching a high of 68.02% in March 2024. Operating expenses and R&D costs are substantial, with general and administrative expenses peaking at £100.90 million in December 2023.
PE: 162.3x
Genus plc, a UK-based company, recently reported full-year sales of £668.8 million, down from £689.7 million last year, with net income dropping to £7.9 million from £33.3 million. Despite these declines, Genus maintains insider confidence with recent share purchases by executives within the past six months. Their board proposed a consistent final dividend of 21.7 pence per share for December 2024 payout. Earnings are forecasted to grow annually by 39%, suggesting potential future value despite current challenges in profit margins and external borrowing risks.
-
Click here and access our complete valuation analysis report to understand the dynamics of Genus.
-
Examine Genus' past performance report to understand how it has performed in the past.
Hammerson
Simply Wall St Value Rating: ★★★☆☆☆
Overview: Hammerson is a property development and investment company specializing in flagship retail destinations across the UK, France, and Ireland, with a market cap of approximately £1.36 billion.